Log in

NYSE:SNN - Smith & Nephew Stock Price, Forecast & News

$47.88
+0.03 (+0.06 %)
(As of 02/18/2020 03:03 AM ET)
Today's Range
$47.16
Now: $47.88
$47.91
50-Day Range
$47.81
MA: $48.68
$50.57
52-Week Range
$37.68
Now: $47.88
$50.69
Volume557,296 shs
Average Volume436,210 shs
Market Capitalization$20.94 billion
P/E Ratio23.70
Dividend Yield1.16%
Beta0.25
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone44-20-7401-7646

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.90 billion
Cash Flow$3.01 per share
Book Value$11.14 per share

Profitability

Miscellaneous

Employees16,377
Market Cap$20.94 billion
Next Earnings Date2/20/2020 (Estimated)
OptionableOptionable

Receive SNN News and Ratings via Email

Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.


Smith & Nephew (NYSE:SNN) Frequently Asked Questions

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a -- dividend on Monday, September 23rd. Shareholders of record on Friday, October 4th will be given a dividend of $0.288 per share on Wednesday, October 30th. This represents a dividend yield of 1.5%. The ex-dividend date of this dividend is Thursday, October 3rd. View Smith & Nephew's Dividend History.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) announced its quarterly earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.39 by $0.59. View Smith & Nephew's Earnings History.

When is Smith & Nephew's next earnings date?

Smith & Nephew is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Smith & Nephew.

What price target have analysts set for SNN?

4 analysts have issued 12 month price objectives for Smith & Nephew's stock. Their forecasts range from $6.00 to $6.00. On average, they anticipate Smith & Nephew's stock price to reach $6.00 in the next year. This suggests that the stock has a possible downside of 87.5%. View Analyst Price Targets for Smith & Nephew.

What is the consensus analysts' recommendation for Smith & Nephew?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Smith & Nephew.

Has Smith & Nephew been receiving favorable news coverage?

Media headlines about SNN stock have been trending very negative recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Smith & Nephew earned a coverage optimism score of -3.4 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Smith & Nephew.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 1,750,000 shares, a decrease of 7.9% from the January 15th total of 1,900,000 shares. Based on an average daily volume of 592,200 shares, the days-to-cover ratio is presently 3.0 days. Approximately 0.4% of the shares of the stock are short sold. View Smith & Nephew's Current Options Chain.

Who are some of Smith & Nephew's key competitors?

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), Gilead Sciences (GILD), RPM International (RPM), AbbVie (ABBV), Alibaba Group (BABA), Enterprise Products Partners (EPD), Pfizer (PFE), AT&T (T), Alexion Pharmaceuticals (ALXN) and Broadcom (AVGO).

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the folowing people:
  • Mr. Namal Nawana, CEO & Exec. Director (Age 48)
  • Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
  • Mr. Mark Gladwell, Pres of Global Operations (Age 44)
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by a variety of of retail and institutional investors. Top institutional investors include WCM Investment Management LLC (0.96%), Nuance Investments LLC (0.76%), Cambiar Investors LLC (0.73%), FMR LLC (0.26%), Bank of America Corp DE (0.26%) and Envestnet Asset Management Inc. (0.15%).

Which institutional investors are selling Smith & Nephew stock?

SNN stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Cambiar Investors LLC, State Street Corp, Connor Clark & Lunn Investment Management Ltd., New York State Common Retirement Fund, Jane Street Group LLC, Barclays PLC and Goldman Sachs Group Inc..

Which institutional investors are buying Smith & Nephew stock?

SNN stock was acquired by a variety of institutional investors in the last quarter, including Nuance Investments LLC, WCM Investment Management LLC, Envestnet Asset Management Inc., Natixis Advisors L.P., Citigroup Inc., Raymond James & Associates, M&T Bank Corp and Stifel Financial Corp.

How do I buy shares of Smith & Nephew?

Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $47.88.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of $20.94 billion and generates $4.90 billion in revenue each year. The medical equipment provider earns $663 million in net income (profit) each year or $2.02 on an earnings per share basis. Smith & Nephew employs 16,377 workers across the globe.View Additional Information About Smith & Nephew.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is http://www.smith-nephew.com/.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 ADAM STREET, LONDON X0, WC2N 6LA. The medical equipment provider can be reached via phone at 44-20-7401-7646 or via email at [email protected]


MarketBeat Community Rating for Smith & Nephew (NYSE SNN)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  374 (Vote Outperform)
Underperform Votes:  631 (Vote Underperform)
Total Votes:  1,005
MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew and other stocks. Vote "Outperform" if you believe SNN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel